Trial reportJournal of clinical hypertension (Greenwich, Conn.)2017
Assessing the accuracy of the OMRON HEM-907XL oscillometric blood pressure measurement device in patients with nondialytic chronic kidney disease.
Trial report in Journal of clinical hypertension (Greenwich, Conn.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Assessing the accuracy of the OMRON HEM-907XL oscillometric blood pressure measurement device in patients with nondialytic chronic kidney disease.Journal of clinical hypertension (Greenwich, Conn.) · 2017Trial
- Factors Associated With Discordant Blood Pressure Measures among Very Old Adults: Results From the Atherosclerosis Risk in Communities (ARIC) Study.Hypertension (Dallas, Tex. : 1979) · 2026Article
- AMPED study: Protocol for a randomized controlled trial of different doses of aerobic exercise training.Hepatology communications · 2024Article
- Comparison of Home and Office Blood Pressure Devices in the Clinical Setting.American journal of hypertension · 2024Article
- Article
- Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics.Trials · 2021Article
- Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension.Journal of hypertension · 2021Article
- Changes in blood pressure according to stature in Mexican adults.Revista de saude publica · 2021Article
- Predictors for Blood Pressure Reduction in American Latinos: Secondary Analysis of the Adelgaza Program Data.Hispanic health care international : the official journal of the National Association of Hispanic Nurses · 2020Article
- Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH.Contemporary clinical trials communications · 2020Article
- Partnering with Churches to Conduct a Wide-Scale Health Screening of an Urban, Segregated Community.Journal of community health · 2020Article
- Automated Office-Based Blood Pressure Measurement: an Overview and Guidance for Implementation in Primary Care.Current hypertension reports · 2019Review
- History and Justification of a National Blood Pressure Measurement Validated Device Listing.Hypertension (Dallas, Tex. : 1979) · 2019Article
- Working to Increase Stability through Exercise (WISE): Study protocol for a pragmatic randomized controlled trial of a coached exercise program to reduce serious fall-related injuries.Contemporary clinical trials · 2018Article
- The ongoing saga of poor blood pressure measurement: Past, present, and future perspectives.Journal of clinical hypertension (Greenwich, Conn.) · 2017Article
- Blood pressure is blood pressure is blood pressure: Or is it?Journal of clinical hypertension (Greenwich, Conn.) · 2017Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
The OMRON HEM-907XL is a commercial oscillometric blood pressure (BP) monitor that was used in the Systolic Blood Pressure Intervention Trial (SPRINT), in which 28% of participants had chronic kidney disease (CKD). This study examined the accuracy of the monitor in nondialytic patients with CKD. Eighty-seven patients met inclusion criteria. The authors used a modified Association for the Advancement of Medical Instrumentation (AAMI) protocol, with one observer recording measurements from the monitor and two blinded physicians obtaining simultaneous aneroid values by auscultation. Using AAMI method 1, there was a 2.5±9.5 mm Hg difference in OMRON and aneroid systolic BP, and a -1.6±6.5 mm Hg difference in diastolic BP. Using AAMI method 2, there was a 5.1±7.4 mm Hg difference in systolic BP and a -0.2±5.4 mm Hg difference in diastolic BP. In patients with CKD, the OMRON HEM-907XL appears to be accurate for measuring diastolic BP, but did not perform as well for systolic BP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.